Molecular Neurobiology

Short Resume

Prof. Dr. rer. nat. Christiane Richter-Landsberg
(married, two children)

  • Graduated in Pharmacy at the University of Marburg
  • Doctorate degree in biology (Dr. rer. nat) from the University of Göttingen with the thesis in neurochemistry at the Max Planck Institute of Experimental Medicine, Göttingen (1975)
  • Post-doctoral fellow at the Department of Neurobiology, Weizmann Institute of Science, Israel (Minerva Fellowship)
  • Three years of post-doctoral work at the Department of Neuroscience, Harvard Medical School, Boston, USA and at the Department of Neurobiology, Stanford Medical School, USA
  • Research assistant and assistant professor at the Department of Biology, University of Bremen, Germany
  • Habilitation in Molecular Neurobiology, University of Bremen (1988)
  • Since 1993: professor and head of the group Molecular Neurobiology/Neurochemistry at the Institute of Biology, University of Oldenburg, Germany

    Teaching activities activities in cell biology and molecular neurobiology

    Publications listed in PubMed

    Books and special issues

    Memberships

    • Society for Neuroscience
    • International Society for Neurochemistry
    • European Society for Neurochemistry (Member of the council)
    • Gesellschaft für Biochemie und Molekularbiologie (GBM) (Kontaktperson für die Universität Oldenburg)
    • German Neuroscience Association (Neurowissenschaftliche Gesellschaft)

    Research interests

    • Biology of oligodendrocytes, the myelin forming cells of the CNS, in health and disease
    • The regulation of oligodendrocyte differentiation in vitro
    • The oligodendroglial cytoskeleton and the microtubule associated protein tau in oligodendrocytes during normal development and pathological situations
    • Molecular signals that are involved in the regulation of death and survival
    • Stress responses in oligodendrocytes (oxidative stress, proteasomal stress) and the role of stress-induced proteins
    • Molecular mechanisms underlying protein aggregate formation as observed in neurodegenerative diseases with glial pathology, such as MSA, PSP and CBD